Exact Mass: 294.0690594
Exact Mass Matches: 294.0690594
Found 90 metabolites which its exact mass value is equals to given mass value 294.0690594,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Estazolam
Estazolam is only found in individuals that have used or taken this drug. It is a benzodiazepine with anticonvulsant, hypnotic, and muscle relaxant properties. It has been shown in some cases to be more potent than diazepam or nitrazepam. [PubChem]Benzodiazepines bind nonspecifically to benzodiazepine receptors, which affects affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell. N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
(3S,4R)-3,4,5-trihydroxy-8-oxospiro[6,7-dihydronaphthalene-5,2-oxolane]-2-carboxylic acid
Aplysin
C15H19BrO (294.06191839999997)
Filiformin
C15H19BrO (294.06191839999997)
Laurinterol
C15H19BrO (294.06191839999997)
A sesquiterpenoid isolated from Laurencia intermedia and Aplysia kurodai and has been found to exhibit antibacterial activity,
Sulfacytine
Sulfacytine is a short-acting sulfonamide. The sulfonamides are synthetic bacteriostatic antibiotics with a wide spectrum against most gram-positive and many gram-negative organisms. However, many strains of an individual species may be resistant. Sulfonamides inhibit multiplication of bacteria by acting as competitive inhibitors of p-aminobenzoic acid in the folic acid metabolism cycle. Bacterial sensitivity is the same for the various sulfonamides, and resistance to one sulfonamide indicates resistance to all. Most sulfonamides are readily absorbed orally. However, parenteral administration is difficult, since the soluble sulfonamide salts are highly alkaline and irritating to the tissues. The sulfonamides are widely distributed throughout all tissues. High levels are achieved in pleural, peritoneal, synovial, and ocular fluids. Although these drugs are no longer used to treat meningitis, CSF levels are high in meningeal infections. Sulfacytine is a competitive inhibitor of the enzyme dihydropteroate synthetase. It inhibits bacterial synthesis of of dihydrofolic acid by preventing the condensation of the pteridine with para-aminobenzoic acid (PABA), a substrate of the enzyme dihydropteroate synthetase. The inhibited reaction is necessary in these organisms for the synthesis of folic acid. C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D013424 - Sulfanilamides
6-Hydroxymethylsulfadimidine
D000890 - Anti-Infective Agents > D013424 - Sulfanilamides
Benzenesulfonamide, 4-amino-N-(5-hydroxy-4,6-dimethyl-2-pyrimidinyl)-
D000890 - Anti-Infective Agents > D013424 - Sulfanilamides
Sulfametomidine
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01E - Sulfonamides and trimethoprim > J01ED - Long-acting sulfonamides C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D013424 - Sulfanilamides
15-Bromo-1,3(15),7-chamigratrien-9-one
C15H19BrO (294.06191839999997)
Cupalaurenol
C15H19BrO (294.06191839999997)
Isolaurenisol
C15H19BrO (294.06191839999997)
Isoaplysin
C15H19BrO (294.06191839999997)
Allolaurinterol
C15H19BrO (294.06191839999997)
Neolaurinterol
C15H19BrO (294.06191839999997)
2-[3-(bromomethylene)-1,2-dimethylcyclopentyl]-5-methylphenol
C15H19BrO (294.06191839999997)
Cyclolaurenol
C15H19BrO (294.06191839999997)
(+)-2-(Bromomethyl)-2,3,4,5-tetrahydro-5,8,10-trimethyl-2,5-methano-1-benzoxepin
C15H19BrO (294.06191839999997)
Isolaurinterol
C15H19BrO (294.06191839999997)
OCP_295.0845_17.0
CONFIDENCE Tentative identification: most likely structure (Level 3); INTERNAL_ID 1303
(2S,3S)-3-O-caffeyl-2,3,4-trihydroxy-2-methylbutan-1,4-olide|3-O-Caffeoyl-2-C-methyl-D-erythrono-1,4-lactone
2-(4,5,5-Trimethyl-1-cyclopentenyl)-4-bromo-5-methylphenol
C15H19BrO (294.06191839999997)
9-((Z)-bromomethylidene)-1,2,5-trimethylspiro<5.5>undeca-1,7-dien-3-one|9-((Z)-bromomethylidene)-1,2,5-trimethylspiro[5.5]undeca-1,7-dien-3-one
C15H19BrO (294.06191839999997)
(3Z,6Z,9Z)-13-bromo-5,12-epoxypentadeca-3,6,9-trien-1-yne
C15H19BrO (294.06191839999997)
(3Z,6Z,9Z)-12-bromo-5,13-epoxypentadeca-3,6,9-trien-1-yne
C15H19BrO (294.06191839999997)
3-(6,8-dimethoxy-1-oxoisochromen-3-yl)-2-hydroxypropanoic acid
estazolam
N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
Sulfacytine
C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D013424 - Sulfanilamides
1,1,1-Trifluoro-N-(1,2,3,4-tetrahydro-1-methyl-7-quinolinyl)-methanesulfonamide
2-n-boc-amino-4-benzothiazole-6-carboxylic acid
C13H14N2O4S (294.06742440000005)
N-[4-chloro-2-(trifluoromethyl)phenyl]-2-propoxyethanimidamide
C12H14ClF3N2O (294.07466999999997)
methyl 2-[(2-chloroacetyl)amino]-3-(1h-indol-3-yl)propanoate
2-tert-Butoxycarbonylamino-benzothiazole-4-carboxylic acid
C13H14N2O4S (294.06742440000005)
3-AMINO-3-[5-(3-CHLORO-4-METHOXYPHENYL)-FURAN-2-YL]-PROPIONIC ACID AMIDE
Ethyl 1-tosyl-1H-imidazole-4-carboxylate
C13H14N2O4S (294.06742440000005)
1,1,1-Trifluoro-2-trifluoromethyl-2-hydroxy-4-pentyl methacrylate
Ethyl 2-(pyrrolidin-1-yl)-4-trifluoromethyl-1,3-thiazole-5-carboxylate
6-chloro-N-(oxan-4-ylmethyl)-5-(trifluoromethyl)pyridin-2-amine
C12H14ClF3N2O (294.07466999999997)
6-METHOXY-3-[4-(TRIFLUOROMETHYL)PHENYL][1,2,4]TRIAZOLO[4,3-B]PYRIDAZINE
(Z)-4-(4-Nitrobenzylidene)-2-phenyloxazol-5(4H)-one
(Z)-4-(2-Nitrobenzylidene)-2-phenyloxazol-5(4H)-one
Sulfaethoxypyridazine
D000890 - Anti-Infective Agents > D013424 - Sulfanilamides
4-(6-METHOXY-BENZOTHIAZOL-2-YLCARBAMOYL)-BUTYRIC ACID
C13H14N2O4S (294.06742440000005)
6-N-Benzyl-2-chloro-5,6,7,8-tetrahydro-1,6-naphthyridine HCl
(E)-2-(4-bromophenyl)-3-cyclohexylprop-2-en-1-ol
C15H19BrO (294.06191839999997)
1-FURFURYL-3-(P-TOLYLSULFONYL)-UREA
C13H14N2O4S (294.06742440000005)
4-(4-Chloro-phenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid ethyl ester
2-(4-methoxyphenyl)imino-3-methyl-4-oxo-1,3-thiazinane-6-carboxylic acid
C13H14N2O4S (294.06742440000005)
2-[2-(3,4-dimethoxyanilino)-1,3-thiazol-4-yl]acetic acid
C13H14N2O4S (294.06742440000005)
3-cyano-4-trifluoromethyl-6-(4-methoxyphenyl)-pyridine-2-one
methyl 2-[1-(4-methylphenyl)sulfonylimidazol-4-yl]acetate
C13H14N2O4S (294.06742440000005)
5-(piperidin-1-ylsulfonyl)-1H-indole-2,3-dione
C13H14N2O4S (294.06742440000005)
N4-(3-chlorophenyl)-N2-methyl-5-nitropyrimidine-2,4,6-triamine
C11H11ClN6O2 (294.06319759999997)
5-Methyl-alpha-((5-nitro-2-furanyl)methylene)-1H-benzimidazole-2-acetonitrile
4-Methyl-alpha-((5-nitro-2-furanyl)methylene)-1H-benzimidazole-2-acetonitrile
(2E)-4-(4-(2-Chlorophenyl)-1-piperazinyl)-4-oxo-2-butenoic acid
1-((2-Hydroxyethoxy)methyl)-5-(phenylthio)pyrimidine-2,4(1H,3H)-dione
C13H14N2O4S (294.06742440000005)
N-(3-acetylphenyl)-3,5-dimethyl-4-isoxazolesulfonamide
C13H14N2O4S (294.06742440000005)
3-Chloro-1-(2,4-dimethylphenyl)-4-(2-hydroxyethylamino)pyrrole-2,5-dione
N4-(4-Chlorophenyl)-N2-methyl-5-nitropyrimidine-2,4,6-triamine
C11H11ClN6O2 (294.06319759999997)
(Z)-3-(3-Chloro-4-hydroxy-5-methoxyphenyl)-2-cyano-N-propan-2-ylprop-2-enamide
3-(6,8-Dimethoxy-1-oxoisochromen-3-yl)-2-hydroxypropanoic acid
Sulfametomidine
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01E - Sulfonamides and trimethoprim > J01ED - Long-acting sulfonamides C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D013424 - Sulfanilamides
4-hydroxy-4-methyl-5-oxooxolan-3-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate
4-bromo-2-[(1s,3r)-1,3-dimethyl-2-methylidenecyclopentyl]-5-methylphenol
C15H19BrO (294.06191839999997)
2-(1-bromopropyl)-9-(but-1-en-3-yn-1-yl)-2,3,6,9-tetrahydrooxonine
C15H19BrO (294.06191839999997)
4-bromo-2-[(1r,3s)-1,3-dimethyl-2-methylidenecyclopentyl]-5-methylphenol
C15H19BrO (294.06191839999997)
4-bromo-1,5,9,12-tetramethyl-8-oxatricyclo[7.2.1.0²,⁷]dodeca-2(7),3,5-triene
C15H19BrO (294.06191839999997)
(6r,9e)-9-(bromomethylidene)-1,5,5-trimethylspiro[5.5]undeca-1,7-dien-3-one
C15H19BrO (294.06191839999997)